199 related articles for article (PubMed ID: 8321240)
1. Both the SH2 and SH3 domains of human CRK protein are required for neuronal differentiation of PC12 cells.
Tanaka S; Hattori S; Kurata T; Nagashima K; Fukui Y; Nakamura S; Matsuda M
Mol Cell Biol; 1993 Jul; 13(7):4409-15. PubMed ID: 8321240
[TBL] [Abstract][Full Text] [Related]
2. v-Crk modulation of growth factor-induced PC12 cell differentiation involves the Src homology 2 domain of v-Crk and sustained activation of the Ras/mitogen-activated protein kinase pathway.
Teng KK; Lander H; Fajardo JE; Hanafusa H; Hempstead BL; Birge RB
J Biol Chem; 1995 Sep; 270(35):20677-85. PubMed ID: 7657647
[TBL] [Abstract][Full Text] [Related]
3. Direct binding of C-terminal region of p130Cas to SH2 and SH3 domains of Src kinase.
Nakamoto T; Sakai R; Ozawa K; Yazaki Y; Hirai H
J Biol Chem; 1996 Apr; 271(15):8959-65. PubMed ID: 8621540
[TBL] [Abstract][Full Text] [Related]
4. Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor- and epidermal growth factor-dependent pathways.
Hempstead BL; Birge RB; Fajardo JE; Glassman R; Mahadeo D; Kraemer R; Hanafusa H
Mol Cell Biol; 1994 Mar; 14(3):1964-71. PubMed ID: 7509449
[TBL] [Abstract][Full Text] [Related]
5. Biological and biochemical activity of v-Crk chimeras containing the SH2/SH3 regions of phosphatidylinositol-specific phospholipase C-gamma and Src.
Matsuda M; Reichman CT; Hanafusa H
J Virol; 1992 Jan; 66(1):115-21. PubMed ID: 1370084
[TBL] [Abstract][Full Text] [Related]
6. Nerve growth factor stimulates the tyrosine phosphorylation of endogenous Crk-II and augments its association with p130Cas in PC-12 cells.
Ribon V; Saltiel AR
J Biol Chem; 1996 Mar; 271(13):7375-80. PubMed ID: 8631760
[TBL] [Abstract][Full Text] [Related]
7. Identification of domains of the v-crk oncogene product sufficient for association with phosphotyrosine-containing proteins.
Matsuda M; Mayer BJ; Hanafusa H
Mol Cell Biol; 1991 Mar; 11(3):1607-13. PubMed ID: 1705010
[TBL] [Abstract][Full Text] [Related]
8. Emerging components of the Crk oncogene product: the first identified adaptor protein.
Matsuda M; Kurata T
Cell Signal; 1996 Aug; 8(5):335-40. PubMed ID: 8911681
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crk-phosphotyrosine-dependent interactions in vitro.
Birge RB; Fajardo JE; Mayer BJ; Hanafusa H
J Biol Chem; 1992 May; 267(15):10588-95. PubMed ID: 1375224
[TBL] [Abstract][Full Text] [Related]
10. Crk interacts with tyrosine-phosphorylated p116 upon T cell activation.
Sawasdikosol S; Ravichandran KS; Lee KK; Chang JH; Burakoff SJ
J Biol Chem; 1995 Feb; 270(7):2893-6. PubMed ID: 7531694
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of NGF induced signal transduction from neurite elongation by expression of a mutant adaptor protein v-Crk in PC12 cells.
Teng KK; Courtney JC; van Bergen en Henegouwen P; Birge RB; Hempstead BL
Mol Cell Neurosci; 1996; 8(2-3):157-70. PubMed ID: 8918832
[TBL] [Abstract][Full Text] [Related]
12. Interaction between the amino-terminal SH3 domain of CRK and its natural target proteins.
Matsuda M; Ota S; Tanimura R; Nakamura H; Matuoka K; Takenawa T; Nagashima K; Kurata T
J Biol Chem; 1996 Jun; 271(24):14468-72. PubMed ID: 8662907
[TBL] [Abstract][Full Text] [Related]
13. v-Crk-induced cell transformation: changes in focal adhesion composition and signaling.
Nievers MG; Birge RB; Greulich H; Verkleij AJ; Hanafusa H; van Bergen en Henegouwen PM
J Cell Sci; 1997 Feb; 110 ( Pt 3)():389-99. PubMed ID: 9057091
[TBL] [Abstract][Full Text] [Related]
14. Src homology region 2 domains direct protein-protein interactions in signal transduction.
Moran MF; Koch CA; Anderson D; Ellis C; England L; Martin GS; Pawson T
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8622-6. PubMed ID: 2236073
[TBL] [Abstract][Full Text] [Related]
15. A 31-amino-acid N-terminal extension regulates c-Crk binding to tyrosine-phosphorylated proteins.
Fajardo JE; Birge RB; Hanafusa H
Mol Cell Biol; 1993 Dec; 13(12):7295-302. PubMed ID: 7504172
[TBL] [Abstract][Full Text] [Related]
16. Four proline-rich sequences of the guanine-nucleotide exchange factor C3G bind with unique specificity to the first Src homology 3 domain of Crk.
Knudsen BS; Feller SM; Hanafusa H
J Biol Chem; 1994 Dec; 269(52):32781-7. PubMed ID: 7806500
[TBL] [Abstract][Full Text] [Related]
17. Physiological signals and oncogenesis mediated through Crk family adapter proteins.
Feller SM; Posern G; Voss J; Kardinal C; Sakkab D; Zheng J; Knudsen BS
J Cell Physiol; 1998 Dec; 177(4):535-52. PubMed ID: 10092207
[TBL] [Abstract][Full Text] [Related]
18. The product of the cellular crk gene consists primarily of SH2 and SH3 regions.
Reichman CT; Mayer BJ; Keshav S; Hanafusa H
Cell Growth Differ; 1992 Jul; 3(7):451-60. PubMed ID: 1329926
[TBL] [Abstract][Full Text] [Related]
19. Targeted expression of an oncogenic adaptor protein v-Crk potentiates axonal growth in dorsal root ganglia and motor neurons in vivo.
Weinstein DE; Dobrenis K; Birge RB
Brain Res Dev Brain Res; 1999 Aug; 116(1):29-39. PubMed ID: 10446344
[TBL] [Abstract][Full Text] [Related]
20. Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins.
Tanaka M; Gupta R; Mayer BJ
Mol Cell Biol; 1995 Dec; 15(12):6829-37. PubMed ID: 8524249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
